These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29019066)

  • 41. A squeeze-type osmotic tablet for controlled delivery of nifedipine.
    Park JS; Shin JH; Lee DH; Kim MS; Rhee JM; Lee HB; Khang G
    J Biomater Sci Polym Ed; 2008; 19(1):31-45. PubMed ID: 18177552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Sandwiched osmotic pump tablet for controlled release of water-insoluble drug].
    Liu LX; Khang G; Rhee JM; Lee HB
    Yao Xue Xue Bao; 2003 Aug; 38(8):620-3. PubMed ID: 14628456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invivo absorption behaviour of theophylline from starch-methyl methacrylate matrix tablets in beagle dogs.
    Fernández-Campos F; Ferrero C; Colom H; Jiménez-Castellanos MR
    Int J Pharm; 2015 Jan; 478(2):684-92. PubMed ID: 25476254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.
    Liu X; Wang S; Chai L; Zhang D; Sun Y; Xu L; Sun J
    Int J Pharm; 2014 Jan; 461(1-2):529-39. PubMed ID: 24374219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delivery of prazosin hydrochloride from osmotic pump system prepared by coating the core tablet with an indentation.
    Liu L; Wang J; Zhu S
    Drug Deliv; 2007 Apr; 14(4):219-24. PubMed ID: 17497354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation.
    Gong W; Ma R; Mei D; Jing P; Dong X; Li B; Yang Y; Du L; Mei XG; Hu FQ
    Drug Deliv; 2014 Feb; 21(1):1-7. PubMed ID: 24102136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation.
    Ochoa L; Igartua M; Hernández RM; Solinís MA; Gascón AR; Pedraz JL
    Eur J Pharm Biopharm; 2010 Jun; 75(2):232-7. PubMed ID: 20159037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel gastric-resident osmotic pump tablet: in vitro and in vivo evaluation.
    Guan J; Zhou L; Nie S; Yan T; Tang X; Pan W
    Int J Pharm; 2010 Jan; 383(1-2):30-6. PubMed ID: 19733646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo evaluation of novel osmotic pump tablets of isosorbide-5-mononitrate containing polyvinyl pyrrolidone (PVP) for controlled release.
    Li X; Jiang Q; Du L; Wang C; Chi Q
    Pharmazie; 2012 Aug; 67(8):695-700. PubMed ID: 22957434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
    Zhang ZH; Wang Y; Wu WF; Zhao X; Sun XC; Wang HQ
    Yao Xue Xue Bao; 2012 Dec; 47(12):1687-95. PubMed ID: 23460977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Per-oral controlled release dosage form of theophylline using soybean protein.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Unitary-core osmotic pump tablet for controlled release of water-insoluble drug].
    Liu LX; Xu Q; Khang G; Rhee JM; Lee HB
    Yao Xue Xue Bao; 2003 Dec; 38(12):966-7. PubMed ID: 15040097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
    Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modelling the controlled drug release of push-pull osmotic pump tablets using DEM.
    Hu J; Zhang L; Li W; He Y; Wu CY
    Int J Pharm; 2024 Jul; 660():124316. PubMed ID: 38857664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of novel immediate-/controlled-release tablets of isosorbide-5-mononitrate (5-ISMN): in vitro-in vivo correlation.
    Li X; Jiang Q; Du L; Li Y; Li M
    Pharmazie; 2014 Feb; 69(2):109-16. PubMed ID: 24640599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system.
    Gong W; Liu Y; Mei DY; Yang M; Mei XG
    Drug Dev Ind Pharm; 2015 Mar; 41(3):464-9. PubMed ID: 24400982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
    Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.